HUMAX

biochemicals; namely, monoclonal antibodies for in vitro or scientific research regarding cancer [, acquired immune deficiency syndrome (AIDS), and other infectious diseases, autoimmune diseases, and cardiovascular diseases ]

monoclonal antibody therapeutic pharmaceuticals for use in the treatment of cancer [, acquired immune deficiency syndrome (AIDS), and other infectious diseases, autoimmune diseases, and cardiovascular diseases ]